DEFINITIVE PROXY STATEMENT

Company

Phio Pharmaceuticals Corp.

Filed

May 8, 2024

Period of Report

June 17, 2024

Accession Number

0001683168-24-003113

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →